Dashboard
1
With ROE of 8.22%, it has a Attractive valuation with a 0.72 Price to Book Value
- Over the past year, while the stock has generated a return of -2.01%, its profits have risen by 23.9% ; the PEG ratio of the company is 0.4
2
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.65%
0%
3.65%
6 Months
1.86%
0%
1.86%
1 Year
33.36%
0%
33.36%
2 Years
29.31%
0%
29.31%
3 Years
-15.77%
0%
-15.77%
4 Years
12.33%
0%
12.33%
5 Years
35.7%
0%
35.7%
Medipower (Overseas) PCL for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.79%
EBIT Growth (5y)
11.25%
EBIT to Interest (avg)
1.94
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.30
Tax Ratio
23.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.60%
ROE (avg)
6.13%
Valuation key factors
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.72
EV to EBIT
3.49
EV to EBITDA
3.49
EV to Capital Employed
0.70
EV to Sales
2.10
PEG Ratio
0.37
Dividend Yield
NA
ROCE (Latest)
20.16%
ROE (Latest)
8.22%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
35.80
35.90
-0.28%
Operating Profit (PBDIT) excl Other Income
22.10
21.80
1.38%
Interest
10.20
8.90
14.61%
Exceptional Items
0.00
-2.20
100.00%
Consolidate Net Profit
8.50
4.00
112.50%
Operating Profit Margin (Excl OI)
618.10%
608.00%
1.01%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is -0.28% vs 3.16% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is 112.50% vs -59.60% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
145.00
142.60
1.68%
Operating Profit (PBDIT) excl Other Income
87.20
86.90
0.35%
Interest
37.50
37.80
-0.79%
Exceptional Items
-1.90
2.50
-176.00%
Consolidate Net Profit
43.90
30.30
44.88%
Operating Profit Margin (Excl OI)
601.20%
609.40%
-0.82%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 1.68% vs 13.08% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 44.88% vs 102.00% in Dec 2023






